Bevacizumab (Bv) in the adjuvant treatment of HER2-negative breast cancer: Final results from Eastern Cooperative Oncology Group E5103.
暂无分享,去创建一个
W. Gradishar | G. Sledge | J. Sparano | K. Fox | C. Hendricks | D. Northfelt | A. Tevaarwerk | A. Brufsky | I. Mayer | L. Goldstein | K. Miller | A. O'neill | Amye J. Tevaarwerk | C. Dang | E. Balcueva | Stuart Bloom